Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05934487Not ApplicableRecruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Role: lead

NCT06783335Recruiting

Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure

Role: lead

NCT03375710Not ApplicableCompleted

SIRONA Trial Heart Failure NYHA Class III

Role: lead

NCT04012944Not ApplicableActive Not Recruiting

SIRONA 2 Trial Heart Failure NYHA Class III

Role: lead

NCT04089059Not ApplicableActive Not Recruiting

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Role: lead

NCT03623165Terminated

PRODIGY Registry in NYHA Class III Heart Failure Patients

Role: lead

All 6 trials loaded